je.st
news
Tag: blindness
Eye cells grown at Johns Hopkins may lead to a cure for some forms of blindness
2015-12-19 10:20:18| Chemicals - Topix.net
Dr Donald Zack, co-director of Center for Stem Cells and Ocular Regenerative Medicine at Johns Hopkins Wilmer Eye Institute, is leading a study that is growing eye cells in the lab and one day could help develop therapies that could stop blindness. Zach shows a cell sorter in his lab at the Smith Building.
Merck Congratulates Awardees of 2015 Nobel Prize in Physiology or Medicine for Discovery Leading to River Blindness Treatment
2015-10-05 23:15:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. Co-recipient Dr. William C. Campbell Conducted his Nobel Prize-winning Work at Merck Research Laboratories KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, proudly congratulates William C. Campbell, a retired scientist from Merck Research Laboratories, who was jointly named the 2015 Nobel Prize winner in Physiology or Medicine with Satoshi Omura for the discovery of avermectin, which led to Mercks development of Mectizan (ivermectin), a treatment for river blindness (also known as onchocerciasis) in Africa, Latin America and Yemen. Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036orClaire Gillespie, 267-305-0932orInvestors:Terri Loxam, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: to
treatment
leading
river
International Coalition Urges Final Push to Eliminate River Blindness from the Americas
2015-09-29 16:30:00| Merck.com - Corporate News
Dateline City: WASHINGTON, ATLANTA, & KENILWORTH, N.J. Country efforts supported by a major public-private partnership - including The Carter Center/OEPA, PAHO/WHO, and Merck & Co., Inc.s Mectizan Donation Program - bring the region closer to achieving the elimination goal by 2020 Mexico latest country to receive verification of elimination by World Health Organization WASHINGTON, ATLANTA, & KENILWORTH, N.J.--(BUSINESS WIRE)--The Carter Center, PAHO/WHO and the Mectizan Donation Program of Merck & Co., Inc. known as MSD outside the United States and Canada, are part of a coalition of organizations helping countries in the Americas fight river blindness (onchocerciasis), and are calling for a final push to definitively eliminate transmission of the disabling disease from the Western Hemisphere. Language: English Contact: Media:PAHOLeticia Linn, 202-974-3440Linnl@paho.orgorThe Carter Center/OEPAEmily Staub, 404-420-5126Emily.Staub@cartercenter.orgorMerck & Co, Inc. (known and MSD outside of the United States and Canada)Veronica Trulin, On-site, 908-656-5590Veronica.trulin@merck.comorLainie Keller, Kenilworth , NJ, 908-236-5036M: +1 908-406-1459Lainie.keller@merck.com Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: international
final
river
push
Peek Vision and Optibrand Ltd., LLC Collaborate to Offer New Hope for Tackling Global Blindness
2014-12-17 11:31:37| Industrial Newsroom - All News for Today
FORT COLLINS, Colo. The team behind Peek, the Portable Eye Examination Kit, and Optibrand Ltd., LLC have announced a collaboration as part of the solution to preventing avoidable blindness by increasing access to potentially life-changing new eye health testing equipment. Peek consists of smartphone apps and an...
Merck Congratulates Ecuador as Second Country to Receive PAHO/WHO Verification of Elimination of River Blindness
2014-10-03 15:00:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, applauds the government of Ecuador on being the second country in the world to receive World Health Organization (WHO) verification of the elimination of river blindness (onchocerciasis) using MECTIZAN (ivermectin). Language: English Contact: MerckJennifer Woodruff, 267-305-3550 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: country
receive
river
ecuador